888-794-0077 info@advancedtherapies.com
  • Twitter
  • Twitter
WuXi Advanced Therapies
  • Manufacturing
    • Phase
      • Clinical Manufacturing
      • Commercial Manufacturing
    • Platforms
      • AAV Vector Suspension
      • Lentiviral Vector
      • Closed Process CAR-T
    • Products
      • Cell Banks
      • Cellular Therapies
      • Viral Products
      • Plasmid Manufacturing
  • Testing
    • Services
      • Analytical Development
      • Cell Line Characterization
      • Lot Release
      • Materials Characterization
      • Viral Clearance Validation
    • Products
      • Advanced Therapies
      • Protein Therapies
      • Vaccines
  • Resources
    • Customer Toolbox
    • Knowlege Library
  • About Us
    • Our Story
    • Careers
    • News
    • Locations
    • Events
  • Contact
    • Sales
    • Support
Select Page

By using this site, you agree to our updated Privacy and Cookie Policy.

Enabling and Supporting Biopharmaceuticals with Integrated Manufacturing and Lab Testing Solutions from Gene of Interest to Global Commercial Launch

CDMO

  • Autologous, allogenic, and Gene Mediated Cell Therapies
  • Viral Vector Supply
  • Cell and Viral Banks
  • Process and analytical development
  • Clinical and Commercial manufacturing
  • In-process/release testing

Learn More

Testing

  • Cell line characterization
  • Bulk product
  • Adventitious agent/Process Residual
  • Viral Clearance
  • Lot Release
  • Container Closure

Learn More

Downstream BioProcessing

Downstream BioProcessing

August 29, 2018

Multi-Channel Micropipette

Multi-Channel Micropipette

August 29, 2018

Plaque Assays

Plaque Assays

August 29, 2018

GMP Viral Vectors in 7-10 Months

GMP Viral Vectors in 7-10 Months

August 29, 2018

  • Terms of Use
  • Privacy Policy
  • Quality
Accelerating Progress and Time to Market
  • Twitter
© Copyright 2020 WuXi AppTec. All Rights Reserved.